IFNA17 and metabolic dysfunction-associated steatotic liver disease: At least, the decrease in “INF-α/γ response” could align with a clinical study indicating that serum INF-α2 was increased in obese NAFLD subjects, with a positive correlation to intramuscular TG accumulation [27].